SpeeDx have announced signing a new distribution partner, further extending customer access to market-leading SpeeDx ResistancePlus® and PlexPCR® tests. Neogen Diagnostik Sağlık Hizmetleri Ltd Şti will distribute all SpeeDx tests throughout...
Roche customers will now have even more opportunities to utilise ResistancePlus® tests to support clinically important treatment decisions. SpeeDx ResistancePlus® MG and ResistancePlus® GC are now validated for cobas z...
Syphilis remains an important public health concern due to global case increases. In Australia, the largest syphilis outbreak ever recorded has been ongoing for the last 10 years, and now...
SpeeDx have partnered with researchers from Nepean Hospital in an exclusive agreement to commercialise a molecular test for IFI27 - a host biomarker with expression strongly correlated with disease progression...
The opening of a PC2 laboratory facility at SpeeDx Sydney headquarters is an exciting milestone to celebrate. SpeeDx performs all commercial functions including research, development and manufacturing out of their...
SpeeDx in partnership with Nepean Blue Mountains Local Health District’s (NBMLHD) Nepean Hospital Intensive Care Unit were awarded funding through the MTPConnect Biomedical Translation Bridge (BTB) program. Funds will support...
Important clinical data published in Clinical Infectious Diseases demonstrated practical effectiveness of Resistance Guided Therapy for treating gonorrhoea. Led by Dr. Jeffrey Klausner, Professor of epidemiology and medicine at UCLA,...
The Academy of Technology and Engineering’s (ATSE) Innovation and Excellence Awards for 2020 announced SpeeDx founders Dr Alison Todd and Dr Elisa Mokany winners of the Clunies Ross Award for...
The pandemic environment of COVID-19 has shined a spotlight on the importance of clinical diagnostics. Now, more than ever, the growth and success of SpeeDx has global reach in terms...
SpeeDx has partnered with Roche, a global pioneer in pharmaceuticals and diagnostics, to expand access to infectious disease and antibiotic resistance tests and technology. Under the terms of the agreement,...